Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)

Hubei Jumpcan Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,476	7,738	4,819	3,819	2,959	2,285
Trading Asset Securities	5,166	3,178	3,045	1,675	1,258	190
Cash & Short-Term Investments	11,642	10,916	7,863	5,494	4,217	2,475
Cash Growth	18.41%	38.82%	43.13%	30.28%	70.40%	55.95%
Accounts Receivable	1,826	2,782	2,850	2,183	2,032	2,055
Other Receivables	13.39	14.99	17.2	11.98	10.33	10.66
Receivables	1,840	2,797	2,867	2,195	2,042	2,065
Inventory	697.64	490.08	391.48	375.59	278.42	338.47
Other Current Assets	40.72	32.5	54.23	58.34	38.13	33
Total Current Assets	14,220	14,235	11,177	8,123	6,576	4,912
Property, Plant & Equipment	2,821	2,922	2,856	3,034	3,141	3,018
Long-Term Investments	426.73	393.97	332.34	328.44	155.33	106.62
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	298.24	305.01	320.62	280.04	283.84	335.83
Long-Term Deferred Tax Assets	32.16	45.45	62.16	57.32	42.62	38.3
Long-Term Deferred Charges	10.85	11.91	3.87	13.19	23.67	4.41
Other Long-Term Assets	72.64	62.16	62.14	127.96	126.51	82.5
Total Assets	18,050	18,144	14,981	12,131	10,516	8,665
Accounts Payable	1,779	2,141	1,505	945.77	452.52	436.09
Accrued Expenses	153.46	246.62	350.39	242.7	207.74	191.44
Short-Term Debt	1,350	1,088	400	-	-	-
Current Portion of Long-Term Debt	-	-	-	627.55	-	-
Current Portion of Leases	1.1	1.06	0.44	1.55	-	-
Current Income Taxes Payable	67.09	182.62	106.09	43.71	69.64	69.39
Current Unearned Revenue	14.67	17.25	49.14	19.34	8.03	15.63
Other Current Liabilities	959.45	915.86	1,016	919.98	1,229	1,127
Total Current Liabilities	4,325	4,592	3,427	2,801	1,967	1,840
Long-Term Debt	-	-	-	-	602.58	576.15
Long-Term Leases	1.22	1.43	0.2	1.02	-	-
Long-Term Unearned Revenue	68.45	71.43	78.19	84.63	90.67	58.29
Long-Term Deferred Tax Liabilities	123.28	109.28	122.05	112.38	90.72	82.97
Other Long-Term Liabilities	0.77	0.82	1.06	1.35	1.67	2.9
Total Liabilities	4,519	4,775	3,629	3,000	2,753	2,560
Common Stock	452.74	452.74	452.74	436.27	436.26	400.24
Additional Paid-In Capital	4,009	3,999	3,984	3,148	3,114	1,766
Retained Earnings	9,151	9,010	6,998	5,431	4,112	3,837
Treasury Stock	-104.52	-111.97	-97.18	-	-	-
Comprensive Income & Other	-	-	-	100.81	100.87	100.89
Total Common Equity	13,508	13,349	11,337	9,117	7,763	6,104
Minority Interest	22.41	19.42	15.14	14.17	-	-
Shareholders' Equity	13,531	13,369	11,352	9,131	7,763	6,104
Total Liabilities & Equity	18,050	18,144	14,981	12,131	10,516	8,665
Total Debt	1,353	1,090	400.65	630.12	602.58	576.15
Net Cash (Debt)	10,289	9,826	7,463	4,864	3,615	1,899
Net Cash Growth	11.03%	31.67%	53.43%	34.56%	90.37%	83.58%
Net Cash Per Share	11.20	10.72	8.22	5.40	4.33	2.33
Filing Date Shares Outstanding	921.81	921.81	921.82	888.27	888.26	814.82
Total Common Shares Outstanding	921.81	921.81	921.82	888.27	888.26	814.82
Working Capital	9,895	9,644	7,749	5,322	4,609	3,072
Book Value Per Share	14.65	14.48	12.30	10.26	8.74	7.49
Tangible Book Value	13,043	12,877	10,849	8,670	7,312	5,601
Tangible Book Value Per Share	14.15	13.97	11.77	9.76	8.23	6.87
Buildings	2,938	2,911	2,455	2,473	2,362	1,815
Machinery	1,689	1,685	1,644	1,566	1,488	1,328
Construction In Progress	192	186.98	352.15	322.17	364.89	725.92

Source: S&P Capital IQ. Standard template. Financial Sources.